Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solosec Safety in Adolescent Girls with Bacterial Vaginosis
NCT03937869Phase 4Completed
- Sponsor
- Lupin Limited
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of secnidazole in bacterial vaginosis (BV), sponsored by Lupin Limited. Started Nov 2018; status: completed.
02
Drugs
secnidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03937869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937869.